Skip to main content
. 2022 Aug 25;13:82. doi: 10.1007/s12672-022-00540-y

Table 3.

Short-term efficacy evaluation

Lesions CR PR SD PD Total
Intracranial 0 0 3 10 13
Neck 10 9 8 11 38
Mediastinum 1 5 4 7 17
Liver 0 0 1 2 3
Abdominal cavity 1 5 3 3 12
Pelvic cavity 0 3 4 10 17
Retroperitoneal lymphatic drainage area 10 11 10 17 48
Vaginal stump 0 6 4 17 27
Others 0 0 1 3 4
Total 22 39 38 80 179